{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T03:12:31Z","timestamp":1761707551885,"version":"3.37.3"},"reference-count":25,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2002,8,1]],"date-time":"2002-08-01T00:00:00Z","timestamp":1028160000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2002,8,1]],"date-time":"2002-08-01T00:00:00Z","timestamp":1028160000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2002,8]]},"DOI":"10.1124\/dmd.30.8.931","type":"journal-article","created":{"date-parts":[[2003,1,15]],"date-time":"2003-01-15T23:17:35Z","timestamp":1042672655000},"page":"931-936","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Amino Acid Residues Affecting the Activities of Human Cytochrome P450 2C9 and 2C19"],"prefix":"10.1016","volume":"30","author":[{"given":"Toshiro","family":"Niwa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Kageyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kae","family":"Kishimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiyasu","family":"Yabusaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumihide","family":"Ishibashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanao","family":"Katagiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.30.8.931_bib1","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/00008571-199412000-00001","article-title":"Biochemistry and molecular biology of the human CYP2C subfamily.","volume":"4","author":"Goldstein","year":"1994","journal-title":"Pharmacogenetics"},{"key":"10.1124\/dmd.30.8.931_bib2","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1021\/bi00173a017","article-title":"Evidence that CYP2C19 is the major (S)-mephenytoin 4\u2032-hydroxylase in humans.","volume":"33","author":"Goldstein","year":"1994","journal-title":"Biochemistry"},{"key":"10.1124\/dmd.30.8.931_bib3","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1046\/j.0306-5251.2001.01499.x","article-title":"Clinical relevance of genetic polymorphysms in the human CYP2C subfamily.","volume":"52","author":"Goldstein","year":"2001","journal-title":"Br J Clin Pharmacol"},{"key":"10.1124\/dmd.30.8.931_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0163-7258(90)90006-N","article-title":"Molecular genetics of the P-450 superfamily.","volume":"45","author":"Gonzalez","year":"1990","journal-title":"Pharmacol Ther"},{"key":"10.1124\/dmd.30.8.931_bib5","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0021-9258(18)48462-1","article-title":"Substrate recognition sites in cytochrome P450 family 2 (CYP2) proteins inferred from comparative analyses of amino acid and coding nucleotide sequences.","volume":"267","author":"Gotoh","year":"1992","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.30.8.931_bib6","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1096\/fasebj.6.2.1537465","article-title":"Characterization of human cytochrome P450 enzymes.","volume":"6","author":"Guengerich","year":"1992","journal-title":"FASEB J"},{"key":"10.1124\/dmd.30.8.931_bib7","doi-asserted-by":"crossref","first-page":"12496","DOI":"10.1074\/jbc.271.21.12496","article-title":"Identification of residues 99, 220 and 221 of human cytochrome P450 2C19 as key determinants of omeprazole activity.","volume":"271","author":"Ibeanu","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.30.8.931_bib8","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/0006-2952(96)00052-4","article-title":"Multiple forms of human P450 expressed in Saccharomyces cerevisiae. Systematic characterization and comparison with those of the rat.","volume":"51","author":"Imaoka","year":"1996","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.30.8.931_bib9","first-page":"783","article-title":"Structure-function relationship analysis of human CYP2C9 and CYP2C19.","volume":"67","author":"Kishimoto","year":"1995","journal-title":"Seikagaku"},{"key":"10.1124\/dmd.30.8.931_bib10","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1006\/abbi.1998.0826","article-title":"Identification of residues 286 and 289 as critical for conferring substrate specificity of human CYP2C9 for diclofenac and ibuprofen.","volume":"357","author":"Klose","year":"1998","journal-title":"Arch Biochem Biophys"},{"key":"10.1124\/dmd.30.8.931_bib11","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1006\/abbi.1998.0615","article-title":"Characterization of CYP2C19 and CYP2C9 from human liver. Respective roles in microsomal tolbutamide, S-mephenytoin and omeprazole hydroxylations.","volume":"353","author":"Lasker","year":"1998","journal-title":"Arch Biochem Biophys"},{"key":"10.1124\/dmd.30.8.931_bib12","doi-asserted-by":"crossref","first-page":"14264","DOI":"10.1021\/bi991195u","article-title":"Diclofenac and its derivatives as tools for studying human cytochromes P450 active sites: particular efficiency and regioselectivity of CYP2Cs.","volume":"38","author":"Mancy","year":"1999","journal-title":"Biochemistry"},{"key":"10.1124\/dmd.30.8.931_bib13","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/00008571-200004000-00008","article-title":"Torsemide metabolism by CYP2C9 variants and other human CYP2C subfamily enzymes.","volume":"10","author":"Miners","year":"2000","journal-title":"Pharmacogenetics"},{"key":"10.1124\/dmd.30.8.931_bib14","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1042\/bj0550416","article-title":"The colorimetric estimation of formaldehyde by means of the Hantzsch reaction.","volume":"55","author":"Nash","year":"1953","journal-title":"Biochem J"},{"key":"10.1124\/dmd.30.8.931_bib15","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1248\/bpb.25.235","article-title":"Inhibition of human hepatic cytochrome P450s and steroidogenic CYP17 by nonylphenol.","volume":"25","author":"Niwa","year":"2002","journal-title":"Biol Pharm Bull"},{"key":"10.1124\/dmd.30.8.931_bib16","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1080\/004982599238731","article-title":"Contribution of human hepatic cytochrome P450s and steroidogenic CYP17 to the N-demethylation of aminopyrine.","volume":"29","author":"Niwa","year":"1999","journal-title":"Xenobiotica"},{"key":"10.1124\/dmd.30.8.931_bib17","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1080\/004982598239290","article-title":"Contribution of human hepatic cytochrome P450 isoforms to regioselective hydroxylation of steroid hormones.","volume":"28","author":"Niwa","year":"1998","journal-title":"Xenobiotica"},{"key":"10.1124\/dmd.30.8.931_bib18","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1016\/S0021-9258(20)82245-5","article-title":"The carbon monoxide-binding pigment of liver microsomes.","volume":"239","author":"Omura","year":"1964","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.30.8.931_bib19","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1006\/bbrc.2000.2538","article-title":"Arginines 97 and 108 in CYP2C9 are important determinants of the catalytic function.","volume":"270","author":"Ridderstrom","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/dmd.30.8.931_bib20","doi-asserted-by":"crossref","first-page":"3247","DOI":"10.1021\/bi00227a012","article-title":"Cloning and expression of complementary DNAs for multiple members of the human cytochrome P450IIC subfamily.","volume":"30","author":"Romkes","year":"1991","journal-title":"Biochemistry"},{"key":"10.1124\/dmd.30.8.931_bib21","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/S0022-3565(25)22379-5","article-title":"Interindividual variation in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians.","volume":"270","author":"Shimada","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.30.8.931_bib22","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S0090-9556(24)15101-X","article-title":"Substrate-dependent effect of acetonitrile on human liver microsomal cytochrome P450 2C9 (CYP2C9) activity.","volume":"28","author":"Tang","year":"2000","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.30.8.931_bib23","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1021\/bi001678u","article-title":"Identification of human CYP2C19 residues that confer S-mephenytoin 4\u2032-hydroxylation activity to CYP2C9.","volume":"40","author":"Tsao","year":"2001","journal-title":"Biochemistry"},{"key":"10.1124\/dmd.30.8.931_bib24","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1248\/bpb1978.4.879","article-title":"A pharmacokinetic analysis program (MULTI) for microcomputer.","volume":"4","author":"Yamaoka","year":"1981","journal-title":"J Pharmacobio-Dyn"},{"key":"10.1124\/dmd.30.8.931_bib25","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1006\/abbi.1997.0302","article-title":"Progesterone and testosterone hydroxylation by cytochrome P450 2C19, 2C9 and 3A4 in human liver microsomes.","volume":"346","author":"Yamazaki","year":"1997","journal-title":"Arch Biochem Biophys"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009095562404491X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009095562404491X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.30.8.931","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T18:17:24Z","timestamp":1739902644000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009095562404491X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,8]]},"references-count":25,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2002,8]]}},"alternative-id":["S009095562404491X"],"URL":"https:\/\/doi.org\/10.1124\/dmd.30.8.931","relation":{},"ISSN":["0090-9556"],"issn-type":[{"type":"print","value":"0090-9556"}],"subject":[],"published":{"date-parts":[[2002,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Amino Acid Residues Affecting the Activities of Human Cytochrome P450 2C9 and 2C19","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.30.8.931","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2002 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}